Fed. Circ. Upholds Invalidity Of J&J Concerta Patent
A federal appeals court has affirmed the invalidity of Johnson & Johnson's patent for attention deficit hyperactivity disorder treatment Concerta, thwarting the health care company's attempt to block Andrx Corp. from...To view the full article, register now.
Already a subscriber? Click here to view full article